Canberra's Canberra Hospital and private medical centres serve Australia's capital region, including a large public service workforce, embassy staff from across the world, and Australian National University's significant international student and academic community. Molnulee provides Canberra pharmacies with affordable, reliable Molnupiravir supply for immunocompromised and high-risk COVID patients across the ACT.
The ACT's well-educated, health-literate population — including scientists, policy analysts, and healthcare workers — creates demand for evidence-based COVID antiviral access. Canberra's ageing federal public service workforce also includes many older adults whose cardiovascular and metabolic risk profiles place them in the high-risk category for COVID-19 severity.
Visit medshopy.com or WhatsApp +91 82650 41513 for Canberra supply.
The ACT's well-educated, health-literate population — including scientists, policy analysts, and healthcare workers — creates demand for evidence-based COVID antiviral access. Canberra's ageing federal public service workforce also includes many older adults whose cardiovascular and metabolic risk profiles place them in the high-risk category for COVID-19 severity.
Visit medshopy.com or WhatsApp +91 82650 41513 for Canberra supply.
Can COVID-19 antivirals like Molnulee interact with common heart or blood pressure medications used by older patients?Molnupiravir (Molnulee) has a comparatively favourable drug interaction profile for older patients on multiple medications. Unlike Paxlovid (which contains Ritonavir — a potent CYP3A4 inhibitor causing interactions with statins, blood thinners, and many other common medications), Molnupiravir does not significantly inhibit or induce major drug-metabolising enzymes. This makes it much safer to use alongside common cardiovascular medications including ACE inhibitors, beta-blockers, calcium channel blockers, most statins, and anticoagulants. This interaction advantage is a key clinical reason Molnupiravir is often preferred for older patients on complex medication regimens — exactly the demographic that both most needs COVID antiviral therapy and most often takes multiple chronic disease medications.
